Bad Drugs

Tag Archive

Uloric Lawsuit Claims and Process

Uloric Lawsuit Claims and Process

| Pharmaceutical Litigation
We trust our doctors and trained medical professionals to take care of us and recommended medications that will keep us safe and healthy and that won’t end up causing more harm than good. Unfortunately, more and more often these days, medications are being shown to have known risks and dangers associated with them. Many of…Read the article
Lemtrada Stroke and Arterial Tears Risk

Lemtrada Stroke and Arterial Tears Risk

| Pharmaceutical Litigation
The U.S. Food and Drug Administration (FDA) has put forth an urgent safety alert, in regards to some rare but very life-threatening risks including stroke and artery rupture. The patients at risk are those who have relapsing forms of multiple sclerosis (MS) and are currently being treated with Lemtrada (alemtuzumab). Since Lemtrada’s approval in 2014 to treat relapsing MS, 13 cases worldwide have been…Read the article
Fentanyl Deaths Reach Epidemic Proportions

Fentanyl Deaths Reach Epidemic Proportions

| Pharmaceutical Litigation
The deadliest drug in America does not come from a shady street corner transaction. It’s available at your local pharmacy. Fentanyl just replaced heroin as the deadliest drug in the United States. Between 2013 and 2016, the Fentanyl overdose rate increased over 500 percent. This drug is now responsible for about 16,000 overdose deaths per…Read the article
Cancer Drug Alert – Dangers of Tasigna

Cancer Drug Alert – Dangers of Tasigna

| Pharmaceutical Litigation
Tasigna (nilotinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Tasigna is used to treat a type of blood cancer called Philadelphia chromosome positive chronic myeloid leukemia (CML). Tasigna is usually given after other medications have been tried without success.   How is Tasigna Given?: Tasigna is a pill, taken by…Read the article
Napoli Shkolnik Appears Before US Supreme Court

Napoli Shkolnik Appears Before US Supreme Court

| Pharmaceutical Litigation
The issue being heard is a challenge to the California Supreme Court’s decision that out of state victims may sue in California. Next week, Plaintiffs, including representatives from Napoli Shkolnik, will appear before the United States Supreme Court.  The Court will consider a challenge to California’s highest court decision which upheld the rule of law…Read the article
Abilify: Link to Compulsive Gambling

Abilify: Link to Compulsive Gambling

| Pharmaceutical Litigation
Abilify is one of the top-selling antipsychotic drugs in the United States. The drug is used to treat bipolar disorder, schizophrenia, and Tourette’s syndrome. However, the drug may be dangerous and lead to compulsive and risky behaviors. Compulsive behaviors linked to Abilify include excessive gambling, risky sexual behavior, and compulsive eating. Many people who have…Read the article
Napoli Shkolnik Featured for Bristol Myers Litigation

Napoli Shkolnik Featured for Bristol Myers Litigation

| Pharmaceutical Litigation
As was reported by Tony Mauro of the NYLJ and Ben Hancock of The Recorder, personal jurisdiction cases are a hot issue right now, with four cases pending before the U.S. Supreme Court. In the Bristol-Myers case, the California Supreme Court ruled that both in-state and out-of-state plaintiffs could sue the pharmaceutical company in California…Read the article
Napoli Shkolnik Noted For Top Product Liability Case

Napoli Shkolnik Noted For Top Product Liability Case

| Pharmaceutical Litigation
Law360 Publishes Year-End Report: Recognizes Napoli Shkolnik PLLC Litigation As One of the Top Product Liability Cases of 2016 Law360 Reviews the most significant product liability ruling of the past year. Law360 has assembled a list of the top Product Liability Cases of 2016 in their Year-End Report and has named Bristol-Myers Squibb Co. v.…Read the article
Hunter Shkolnik Co-Chair of Mass Tort Conference

Hunter Shkolnik Co-Chair of Mass Tort Conference

| Napoli Shkolnik News
Hunter is proud to be the Co-Chair of HarrisMartin’s California Mass Tort and Class Action Litigation Conference: The Impact of Daimler and BMS-Plavix. Partners Shayna Sacks and Jennifer Liakos will be also be Speakers at the event being held October 28 at Hotel Nikko San Francisco. Join them at the following Panels: The History of…Read the article
Court Says Out-of-State Victims May Sue in California

Court Says Out-of-State Victims May Sue in California

| Pharmaceutical Litigation
California’s highest court upheld the rule of law that out-of-state victims can join California residents in suing a pharmaceutical company in California State Court where the claims and injuries are similar. This decision held that Bristol Myers Squibb, already being sued by hundreds of California residents for its marketing of the popular drug Plavix, is…Read the article